Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized Open-Label Study of the Tolerability and Efficacy of Clarithromycin and Ethambutol in Combination With or Without Clofazimine for the Treatment of Disseminated MAC (dMAC) in Patients With AIDS

NCT00002331 is registered in ClinicalTrials.gov with Abbott as lead sponsor.

NCT NCT00002331
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00002331 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized Open-Label Study of the Tolerability and Efficacy of Clarithromycin and Ethambutol in Combination With or Without Clofazimine for the Treatment of Disseminated MAC (dMAC) in Patients With AIDS
Lead sponsor
Abbott
Phase
Not applicable
Overall status
Completed
Start date
January 31, 1994
Completion date
March 31, 1995
Enrollment
Not reported
Sites
18

Conditions

As the registry lists them; a condition with its own page is linked.

hiv infections, mycobacterium avium-intracellular infection